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A B S T R A C T
Zearalenone is a widespread mycotoxin with high estrogenic activity. This study aimed to characterize the
exposure of ZEN in a Chinese population during harvest season in 2016. Exposure to ZEN was measured using
both duplicate diet method and human biomonitoring approaches. Duplicate diet samples from 199 individuals
(4–80 years old) and their following morning urine samples were collected and analyzed using LC-MS/MS
methods sensitive for ZEN, ZAN, α/β-ZEL and α/β-ZAL. ZEN was detected in 59.8% of the food samples at a
mean level of 1.21 ± 2.15 μg/kg. The estimated daily intake (EDI) of ZEN was calculated from food con-
tamination and consumption data at a mean level of 25.6 ± 38.6 ng/kg bw/day, representing 10.2% of the
tolerable daily intake (TDI) set by EFSA and 5.1% of the provisional maximum tolerable daily intake (PMTDI) set
by JECFA, respectively. Wheat appears to be the main diet source of ZEN exposure, contributing over 80% of the
mean EDI. Children had the highest EDI at 37.5 ± 56.3 ng/kg bw/day (p < 0.05). Urine samples were
analyzed both before and after enzymatic hydrolysis to determine the free and total amounts of ZEN biomarkers.
The majority of ZEN was excreted as conjugates with the mean fZEN/tBM ratio of 25.4%. Adolescents had the
highest excretion of ZEN biomarkers among all age groups (p < 0.05). Probable daily intake (PDI) was cal-
culated from ZEN biomarkers and an excretion rate of 36.8%, giving a mean value of 41.6 ± 65.5 ng/kg bw/
day. Significant correlation between internal and external exposure measurement was evidenced in this study
(r = 0.344, p < 0.01). Although the mean PDI was approximately 1.6 times the mean EDI, these two ap-
proaches resulted in similar calculated degrees of ZEN exposure, both markedly below the health-based guidance
value. This study is the first to compare ZEN exposure in a same population based on both diet study and human
biomonitoring approaches. Significant differences of PDI/EDI ratios were found in different age groups
(p < 0.05), possibly indicative of diversified excretion capabilities and metabolism patterns within the popu-
lation.
1. Introduction
Zearalenone (ZEN) is a secondary metabolite biosynthesized mainly
by Fusaruim graminearum, Fusarium culmorum, Fusarium equiseti and
Fusarium sacchari (EFSA, 2011). It contaminates various key grains,
such as wheat, maize, millet and rice, and also occurs in cereal products
and animal-derived food attributed to the carry-over from con-
taminated raw materials and feed. In mammals, ZEN is partially me-
tabolized into stereo-isomeric metabolites α-/β-zearalenol (ZEL), α-/β-
zearalanol (ZAL), and to a lesser extent zearalanone (ZAN), which can
subsequently conjugate with glucuronic acid or sulfuric acid and be
excreted in urine (Warth et al., 2013). In host plants, during fungal
infection, ZEN can also be metabolized into its modified forms via
Phase I and Phase II reactions. Reductive Phase I metabolites α-/β-ZEL,
α-/β-ZAL, ZAN, and their phase II products such as glucosides and
sulfates can be produced by Fusarium and occur in crops, with the
amounts varying from a few up to 100% of ZEN (EFSA, 2016; Lorenz
et al., 2019).
Despite their relatively low acute toxicity, ZEN and its derivatives
exhibit potent estrogenic activity and are suspected as triggers for hy-
perestrogenism in humans (Zinedine et al., 2007) and central pre-
cocious puberty development in girls (Massart et al., 2008). ZEN has
also been evidenced to be hepatotoxic, immunotoxic and genotoxic
(Marin et al., 2013), and it is categorized as a Group 3 carcinogen by
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IARC (IARC, 1993). Based on comprehensive hazard assessments for
ZEN, the Joint FAO/WHO Expert Committee on Food Additives
(JECFA) set a provisional maximum tolerable daily intake (PMTDI) as
0.5 mg/kg bw/day for ZEN in 2000 (JECFA, 2000), while recently EFSA
proposed a group TDI of 0.25 mg/kg bw/day for ZEN and its modified
forms (EFSA, 2016). According to these health-based guidance values
(HBGVs), many countries or regions have established regulatory limits
for ZEN to protect public health. The maximum levels (MLs) of ZEN
fixed by the European Union range from 20 μg/kg for processed cereal/
maize-based foods and baby foods for infants and young children to
400 μg/kg for refined maize oil (European Commission, 2007). In
China, the MLs of ZEN in cereal/maize-based foods are 60 μg/kg
(National Health Commission of PRC, China Food and Drug
Administration, 2017).
Humans are easily exposed to ZEN via ingestion of contaminated
food. The assessment of exposure level, usually called estimated daily
intake (EDI), has been conventionally determined by combining the
occurrence of ZEN in food with consumption data (Aldana et al., 2014;
Cano-Sancho et al., 2012; EFSA, 2011; Bol et al., 2016). Since 2011,
EFSA has launched a series of dietary exposure assessments on ZEN
(EFSA, 2011) and its modified forms (EFSA, 2014; EFSA, 2016) in
Europe to evaluate the chronic dietary exposure to ZEN for different age
and consumer groups. Based on a total of 22,952 analytical results on
ZEN occurrence in food provided by 19 European countries and food
consumption data recorded in the EFSA Comprehensive European Food
Consumption Database, a low risk for all age groups has been concluded
(EFSA, 2011). Besides, ZEN has also been included in several national
and regional total diet studies (TDSs), such as the first and second
French TDS (Sirot et al., 2013), Netherlands TDS (Sprong et al., 2016),
Spanish TDS (Eduardo et al., 2013), Hong Kong TDS, and the fourth
(Wu and Li, 2015) and fifth (Wu et al., 2018) China TDS. All the results
have evidenced a low health risk from ZEN dietary exposure.
Considering the feature of heterogeneous distribution of mycotoxins
in food (Malik et al., 2010) and the probable insufficient representation
of consumption data, an alternative strategy of human biomonitoring
that directly measures mycotoxin biomarkers in human biological
samples and then calculates a probable daily intake (PDI) using the
corresponding excretion rate has been proposed (Baldwin et al., 2011;
Routledge and Gong, 2011; Turner et al., 2012). It enables a less biased
estimation and has gained increased acceptance in recent years. Be-
sides, biomarker-based approaches cover almost all the possible sources
of exposure such as diet, pharmaceuticals, environment, and occupa-
tional route, but still hardly identify the principal sources. These ap-
proaches have been widely adopted for internal exposure assessment of
aflatoxin (Polychronaki et al., 2008; Romero et al., 2010) and deox-
ynivalenol (Ali et al., 2016; Wallin et al., 2013; Deng et al., 2018),
whose biomarkers have been well studied and validated showing reli-
able and stable excretion rates (Cheng et al., 1997; Zhu et al., 1987;
Wild and Turner, 2002; Turner et al., 2010; Fromme et al., 2016). For
ZEN exposure, however, the metabolism and excretion pattern have not
been thoroughly investigated. It is commonly considered that the total
amount of urinary ZEN and its metabolites (free + conjugated) might
be an appropriate biomarker to evaluate ZEN exposure (Mally et al.,
2016). Up to now, only a few internal exposure studies have been
carried out, most of which indicate a low ZEN exposure (Solfrizzo et al.,
2014; Wallin et al., 2015; Föllmann et al., 2016; Li et al., 2018; Ali and
Degen, 2018; Ali and Degen, 2019), despite the results of some in-
dividuals from the US (Bandera et al., 2011) and South Africa
(Shephard et al., 2013) exceeding the HBGVs. However, most of the PDI
was estimated using a piglet excretion data (Gambacorta, et al., 2013),
owing to the lack of representative and large-scale studies on ZEN ex-
cretion pattern in humans. Only two sporadic studies have been re-
ported for single volunteer (Warth et al., 2013; Mirocha et al., 1981),
giving the excretion rate varying from 9.4%~20%. As a consequence,
the internal exposure assessment for ZEN might be considered a rough
estimate.
Until now, dietary exposure and internal exposure to ZEN have still
been performed separately, with no exploration of their relationships and
differences. In this study, a comprehensive exposure assessment of ZEN was
made for the first time based on both the diet study and human biomoni-
toring. The duplicate diet of staple food and the following morning urine
were collected and analyzed using reliable and sensitive LC-MS/MS
methods established previously that have been adopted in China TDS (Wu
and Li, 2015; Wu et al., 2018) and human biomonitoring study (Li et al.,
2018). The occurrence and main food sources of ZEN, biomarker species
and levels in urine, detailed analysis by gender and age groups, dietary and
internal exposure, and their comparison were all discussed.
2. Materials and methods
2.1. Chemicals and materials
The following certificated standard solutions of ZEN and its meta-
bolites were purchased from Biopure (Tulln, Austria): ZEN (100 μg/
mL), α-ZEL (10 μg/mL), β-ZEL (10 μg/mL), ZAN (10 μg/mL), α-ZAL
(10 μg/mL), β-ZAL (10 μg/mL), and 13C18-ZEN (3 μg/mL). LC/MS-grade
acetonitrile and methanol were purchased from Fisher Scientific
(Leicestershire, UK). LC/MS-grade ammonia acetate, formic acid, and
acetic acid were purchased from Merck (Darmstadt, Germany). The
Oasis PRiME HLB 96-well μElution plate (3 mg) and CORTECS™UPLC®
C18 column (2.1 × 100 mm, 1.6 μm) were obtained from Waters
(Milford, MA, USA). The β-glucuronidase from E. coli (6.9 × 105 U/g
solid) was from Sigma-Aldrich (MO, USA) and dissolved in 75 mM
phosphate buffer (pH 6.8), for enzymatic treatment of urine samples.
2.2. Study subjects
The study was conducted on 199 healthy volunteers (96 males and
103 females) from 74 families living in rural area of Anhui province in
China during September 2016. The subjects agreed to provide basic
physical information, 24-h duplicate food portions, and urine samples
the following morning. The basic information (name, gender, and age)
of participants were obtained from their ID cards. The study protocol
was approved by the ethics committee of China National Center for
Food Safety Risk Assessment (No. 2016030063). The adult volunteers
or parents on behalf of their children were fully informed of the study
details and provided written informed consent for participation.
2.3. Duplicate diet sample collection
Here, 199 participants from 74 families were recruited to collect
duplicate diet samples over a 24 h period. They were informed about
the sampling procedure and instructed how to collect and store diet
samples. Their physical information (height and body weight) was
measured and recorded by the investigators on the day of training just
before the 24 h period. As cereal is the main source of ZEN, only cereal-
based foods and beverages (such as beer) were collected in this study.
For each food sample, the participants placed duplicate amounts of
their consumed food items into polyethylene bottles. Food categories
and consumer names were written on the provided label on the outside
of the bottle. The food samples were stored in a cooler with ice packs
until the investigators collected the coolers in the following morning
and took them to a local CDC laboratory, where each individual food
item was weighed and recorded by the investigators. Then the same
food samples collected by members of the same household were pooled
together and homogenized for further analysis, since family members
shared the same food. A total of 244 cereal samples were finally ob-
tained, and an aliquot of each sample was transported to the NHC Key
Laboratory of Food Safety Risk Assessment in Beijing and stored at
−70 °C until further analysis. In this sampling strategy, family mem-
bers shared the same data on ZEN concentration in food consumed and
had individual respective consumption data.
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2.4. Urine sample collection
Urine samples were collected from each participant the following
morning after the food sampling. Urine samples were kept frozen at
−70 °C until analysis.
2.5. Experimental analysis of food and urine samples
ZEN and its five derivatives of ZAN, β-ZEL, α-ZEL, β-ZAL and α-ZAL
in food were analyzed using an isotope dilution method adapted from
China Total Diet Study (Wu et al., 2017). Briefly, food samples were
ultrasonized and centrifuged following the addition of isotope internal
standard 13C-ZEN and 10 mL extract solvent (acetonitrile/water mix-
ture, 86/14) into 2 g of the samples. The supernatants were purified
with MultiSep 226 columns (Romer Labs, Union, MO, USA), eluted with
3 mL methanol, dried under nitrogen, and reconstituted in 1 mL acet-
onitrile-0.2% formic acid solution (v/v = 20/80) for LC-MS/MS ana-
lysis. In this method, food samples were not subjected to a hydrolysis
(by acid or enzyme) that could cleave conjugated forms of metabolites.
Only the free forms of ZEN, α-/β-ZEL, α-/β-ZAL, and ZAN were mea-
sured.
Both free and total amounts of ZEN, α- ZEL, β-ZEL, ZAN, α-ZAL, and
β-ZAL in urine were analyzed using a method published previously (Li
et al., 2018). Briefly, urine samples were thawed and centrifuged prior
to the addition of 13C-ZEN internal standard. The pH was adjusted to
6.8 with phosphate buffer. Then, β-glucuronidase (1000 U/mL urine)
was added into the urine and incubated in a shaking water-bath over-
night at 37 °C for complete hydrolysis of glucuronides (see supple-
mentary material). For analysis of free ZEN and its metabolites, this
enzymatic hydrolysis step was omitted. An Oasis ® PRiME HLB μElution
Plate was used for high throughput cleanup, allowing dozens of samples
to be prepared simultaneously prior to LC-MS/MS analysis. The method
was validated in accordance with the guidelines defined by the EMEA
(European Medicines Agency, 2011) and FDA (FDA, 2018), showing
satisfactory recoveries ranged 94.1–116% for all the analytes (Li et al.,
2018).
The LC-MS/MS measurements of food and urine samples were
performed on an ACQUITY UPLC™ I-Class system coupled to a Xevo®
TQ-S tandem quadrupole mass spectrometer (Waters, MA, USA). For
chromatographic separation, a CORTECS™UPLC® C18 column
(2.1 × 100 mm, 1.6 μm) from Waters set at 40℃ was applied. A linear
gradient of methanol/acetonitrile (80/20, v/v, solvent B) and water
(solvent A) was used as mobile phase as follows: 50–66% B in 0–4 min,
66–90% B in 4–4.1 min, 90% B for 4.1–6.0 min, 90–50% B in
6.0–6.1 min and left to equilibrate for 1.9 min before the next run. The
flow rate was 0.4 mL/min. MS/MS analysis was in ESI negative multi
reaction monitoring (MRM) mode. Other detailed MS/MS parameters
were also described (Li et al., 2018). The limit of detection (LOD) of the
analytes ranged 0.04–0.20 μg/kg in food and 0.02–0.06 ng/mL in urine,
respectively, as summarized in Table 1.
2.6. Statistical analysis
For statistical analysis, concentrations below LOD (undetectable)
were set to LOD/2 of the respective compound. The variables were
analyzed with ANOVA, Kruskal-Wallis test, and Mann-Whitney rank
test to investigate the differences among different subgroups (age,
gender). The correlation between EDI and PDI was evaluated using
Spearman test. Statistical analysis was performed using SPSS, version
22 (SPSS, Chicago, IL, USA). A p-value < 0.05 was considered statis-
tically significant.
3. Results and discussion
3.1. Demographic characteristics
The study cohort consisted of 199 participants; 96 were male and
103 were female. The male participants were between 4 and 78 years
old, and the female subjects were between 4 and 80 years old. Four
different age groups were considered: 37 children (4–12 years), 28
adolescents (13–18 years), 83 adults (18–65 years), and 51 elders
(> 65 years). The demographic characteristics of the subjects are
shown in Table S1.
The study population in Anhui province located at lower basins of
the Yangtze and Huaihe Rivers in east China was likely to be at rela-
tively high risk of exposure to mycotoxins. In this region, outbreaks of
head blight and ear rot, Fusarium fungal diseases of wheat and maize
producing mycotoxins are frequent. Two previous studies reported si-
milar results in Anhui province: ZEN contaminated 70% of the wheat
with mean level of 34.2 μg/kg (Xiong et al., 2009) and contaminated
68.7% of the wheat with mean level of 25.7 μg/kg (Xu et al., 2019).
Both did not investigate ZEN masked forms. Our study was carried out
during September, the harvest season of wheat. Moreover, the popu-
lation preferred the local homemade food, thus, their exposure to ZEN
mainly came from local contamination.
3.2. Duplicate diet analysis
3.2.1. Food consumption
The consumption data was obtained via practical measurements at
duplicate diet collection sites. In total, 244 cereal food samples in 15
categories were collected. For each food category, the average daily







where Consumptionj is the average daily consumption of the food ca-
tegory j (g/person/day), Consumptioni is the individual consumption of
food category j for each participant (g/person/day), and n is the
number of participants in this study (n = 199 for the entire population,
n = 96 for the males, and n = 103 for the females). The detailed in-
formation is shown in Table S2. Steamed bun, noodles, rice porridge,
steamed rice, baba (local pancake), and jiaozi (local dumpling) ac-
counted for 97.4% of the staple food consumption. Other food items
rarely consumed, such as steamed twisted roll, cookies, cornmeal por-
ridge, and crispy rice were classified as “others” (Fig. 1 and Table S2).
Wheat and rice were the predominant cereal sources. Comparing the
mean daily consumption of food categories between genders, males
tended to consume more staple foods, while the diet of female parti-
cipants was more diversified.
3.2.2. ZEN occurrence in food
The contaminated levels of ZEN, ZAN, α-ZEL, β-ZEL, α-ZAL and β-
ZAL in 244 staple food samples were analyzed. The results indicated
that 59.8% (146/244) of samples were ZEN positive, with an average
(± SD) concentration of 1.21 ± 2.15 μg/kg. β-ZEL only existed in a
cookie sample at 1.07 μg/kg. This cookie sample also had the highest
ZEN concentration of 19.3 μg/kg, below the EU maximum limit for ZEN
in processed cereal-based foods (50 μg/kg). ZAN, α-ZEL, α-ZAL, and β-
ZAL were not detected in any of the food samples. The occurrence of
ZEN in separate food categories is summarized in Fig. 2(A). Cookie
(19.3 μg/kg), crispy rice (13.5 μg/kg) and cornmeal porridge (10.6 μg/
kg) were found to be the most heavily contaminated, but they were
Table 1
Limits of detection of the analytical methods for food and urine samples.
Sample ZEN ZAN α-ZEL β-ZEL α-ZAL β-ZAL
Food (μg/kg) 0.04 0.04 0.10 0.10 0.20 0.20
Urine (ng/mL) 0.02 0.03 0.04 0.06 0.04 0.02
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rarely consumed. Only one sample of each category was consumed and
collected in this study (Table S3). For the commonly consumed food
categories, the highest mean level of ZEN was found in baba
(3.52 ± 3.06 μg/kg), a local sticky pancake made of glutinous rice
(Oryza sativa L. var. Glutinosa Matsum). According to the cereal sources,
the diet samples were divided into maize, wheat, rice, glutinous rice,
and sweet potato groups. Among these five groups, the mean level of
ZEN was in the order of maize > glutinous rice > wheat > rice >
sweet potato (p < 0.01), as showed in Fig. 2(B). Therefore, from the
perspective of contamination level, foods made from maize, glutinous
rice, and wheat need more attention regarding ZEN contamination.
3.3. Dietary exposure assessment
3.3.1. ZEN dietary exposure
The individual estimated daily intake (EDI, in ng/kg bw/day) of








where Ti is the concentration of ZEN in the foodstuff i (i = 1,…, p) (ng/
g); Fi is the consumption of the foodstuff i in a day (g/d); and W is the
individual body weight (kg). The EDIs of ZEN for different populations
are presented in Table 2, ranging from 1.43 to 344 ng/kg bw/day, with
a mean level of 25.6 ± 38.6 ng/kg bw/day. This was slightly higher
than the national average level of 21.8 ng/kg bw/day from 5th China
total diet study (Wu et al., 2018). Only two of the participants (1.0%)
had ZEN dietary exposure exceeding the EFSA’s TDI of 0.25 μg/kg bw/
day. They were from the same family and both consumed a large
amount of noodles containing a relatively high level of ZEN (13.7 μg/
kg). The mean level of EDI was slightly higher for males
(28.1 ± 49.9 ng/kg bw/day) than for females (23.2 ± 23.8 ng/kg
bw/day), but the difference was not statistically significant
(p = 0.588). Among the four age groups, children had the highest EDI
(p < 0.05) of 37.5 ± 56.3 ng/kg bw/day, equivalent to approxi-
mately 15.0% of EFSA’s TDI (0.25 μg/kg bw/day) and 7.5% of the
PMTDI set by JECFA (0.5 μg/kg bw/day).
3.3.2. Food contribution to dietary exposure
The contributions of food categories to the dietary ZEN intake were
investigated (Fig. 3). The steamed bun (34.0%), noodles (35.9%), and
jiaozi (7.7%), which are mainly made from wheat, contributed 77.6%
of ZEN dietary exposure. The rice products, including rice porridge
(8.4%), steamed rice (2.6%) and baba (5.4%), contributed only 16.4%.
Although the ZEN level in maize-derived food was relatively high, the
consumption of maize was rather low. In this study, only one maize-
derived food was consumed and collected. As a result, ZEN exposure
from maize was very low, accounting for 2.1% of the total, within the
population.
It is worth noting that only cereal foods were collected in this study,
and the conjugated forms of masked ZEN (Phase II metabolites) were
not measured in food analysis. Both might lead to an underestimation of
ZEN dietary exposure.
3.4. Human biomonitoring
3.4.1. Urinary ZEN biomarkers
The high sensitivity of our analytical method guaranteed reliable
human biomonitoring of ZEN and its metabolites. Both free and total
(free + conjugated) amounts of ZEN and its metabolites (α-ZEL, β-ZEL,
ZAN, α-ZAL, and β-ZAL) in 199 urine samples were obtained by ana-
lysis before and after enzymatic hydrolysis.
Only ZEN was detected in free form (fZEN). Of the 199 samples, 42
(21%) were found positive for fZEN, only 12 (6%) of which had
quantifiable levels, with the mean and highest concentration of
0.022 ng/mL and 0.335 ng/mL, respectively. Among the four age
groups, adolescents had the highest urinary fZEN at 0.0459 ng/mL on
average (p < 0.01). These results are consistent with those of previous
studies that did not perform enzymatic hydrolysis. The parent com-
pound ZEN and its metabolites were scarcely detected in Germany,
Bangladesh, Haiti (Gerding et al., 2014; Gerding et al., 2015), Belgium
(Ediage et al., 2012; Heyndrickx et al., 2015; Huybrechts et al., 2015),
Cameroon (Abia et al., 2013; Ediage et al., 2013), Thailand (Warth
et al., 2014), Nigeria (Ezekiel et al., 2014), China (Henan Province) (Li
et al., 2018), and China (Nanjing City) (Fan et al., 2019), all showing
positive rates lower than 10%. One exception is a US study, in which
free forms of ZEN and its metabolites were detectable in 78.5% of 163
girls, aged 9 and 10 years (Bandera et al, 2011). Another study in
Portugal reported detectable fZEN in about half of 95 urine samples
(Martins et al, 2019).
After β-glucuronidase digestion, free and conjugated forms were
detected as total ZEN, α-ZEL, β-ZEL, ZAN, α-ZAL, and β-ZAL. Total
ZEN, α-ZEL and β-ZEL were detected in 175 (87.9%), 51 (25.6%), and
48 (24.1%) urine samples. Total ZAN, α-ZAL and β-ZAL were not de-
tected. The average total (free + conjugated) amounts of ZEN (tZEN),
α-ZEL (tα-ZEL), and β-ZEL (tβ-ZEL) were 0.383 ng/mL, 0.089 ng/mL,
and 0.142 ng/mL, respectively. The positive rates and concentrations of
the analytes greatly increased after enzymatic treatment. Therefore, if
the urine sample is not processed via enzymatic treatment, the assess-
ment of ZEN exposure will be dramatically underestimated. ZEN and its
phase I metabolites, α-ZEL and β-ZEL, are excreted in urine mainly in
their glucuronide forms via Phase II metabolism. Recently, Phase II
metabolism by sulfation of ZEN and its reduced metabolites has been
evidenced in Caco-2 cells (Pfeiffer et al., 2011) and in human placenta
(Warth et al., 2019). However, ZEN sulfates have not been found in
human urine so far, even though pure ZEN at a rather high level was
ingested by a volunteer (Mirocha et al., 1981). Therefore, β-glucur-
onidase was used in this study, and the results can represent most of
ZEN urinary metabolites.
From the urinary results, ZEN-glucuronides were the major meta-
bolites in human urine. Hence, the tZEN (free + conjugates of ZEN)
could be the most sensitive biomarker for human biomonitoring in
urine. The total amount of ZEN biomarkers (tBM) calculated as the sum
of tZEN, tα-ZEL, and tβ-ZEL was employed to estimate the internal
exposure. The tBM ranged from 0.060 to 6.35 ng/mL, with a mean
concentration of 0.615 ng/mL. No significant gender and age differ-
ences were observed for tBM levels, but the urinary tZEN levels were
different (p < 0.05) among age groups, with the highest level in
adolescents followed by children, adults, and elders. Both fZEN and
tZEN levels in adolescents were significantly higher than other age
groups. The results of urinary ZEN biomarkers are summarized in
Fig. 1. Comparison of the mean consumption in food categories between males
and females.
S. Zhang, et al. Environment International 142 (2020) 105852
4
Fig. 2. Mean concentrations of ZEN in food categories (A) and cereal sources (B). Error bars represent the standard deviation. *There was only one maize-based
sample (cornmeal porridge sample) and one sweet potato-based sample (sweet potato porridge) in the food samples.
Table 2
Estimated daily intake of ZEN for different populations (ng/kg bw/day).
Age Number (M/F) Total Male Female
Mean ± SD Median P90 Mean ± SD Median P90 Mean ± SD Median P90
Children
3-12y
37 (16/21) 37.5 ± 56.3 20.1 83.4 51.6 ± 82.4 20.1 230 26.7 ± 18.4 20.1 55.9
Adolescents
13-18y
28 (15/13) 19.3 ± 11.8 16.5 39.5 14.8 ± 8.35 12.2 30.5 24.5 ± 13.4 19.6 45.4
Adults
19-65y
83 (40/43) 25.3 ± 44.4 13.2 39.5 27.8 ± 55.0 14.0 39.8 22.9 ± 32.0 13.1 47.3
Elders
> 65y
51 (25/26) 20.8 ± 13.1 17.4 45.6 21.4 ± 11.8 18.6 44.2 20.2 ± 14.5 14.9 53.2
Total 199 (96/103) 25.6 ± 38.6 15.7 46.3 28.1 ± 49.9 16.0 43.8 23.2 ± 23.8 15.7 48.4
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Table 3, and the detailed concentrations of fZEN and tBM for different
ages and genders are shown in Table 4.
Results of recent human biomonitoring studies with and without
enzymatic hydrolysis of urine samples were compared in Table 5. For
the hydrolyzed urine samples, the positive rates of ZEN were much
higher than those in unhydrolyzed samples. The average tBM was about
eight times higher in our study than in 252 Swedish adults (tBM at
0.080 ng/mL) (Wallin et al., 2015), three times higher than in 52 re-
sidents in Southern Italy (tBM at 0.224 ng/mL) (Solfrizzo et al., 2014)
and 62 residents in Bangladesh (Ali and Degen, 2019), more than two
times higher than in 60 German adults (tBM at 0.2–0.3 ng/mL) (Ali and
Degen, 2018), and 1.6 times higher than in 301 residents in Henan,
China (tBM at 0.374 ng/mL) (Li et al., 2018). While tBM in this study
was similar to that in a study of 54 female adults in South Africa
(Shephard et al., 2013), it was three times lower than the tBM in a study
of 163 girls in the USA (Bandera et al., 2011). These tBM levels reflect
ZEN exposure in different cohorts.
In our study, urinary levels of tα-ZEL were found to be lower than
those of tβ-ZEL, with a ratio of 0.63 (tα-ZEL/tβ-ZEL). The sum of tα-ZEL
and tβ-ZEL accounted for only 37.6% of the tBM, which is much lower
than tZEN (62.3% of the tBM). The tα-ZEL/tβ-ZEL ratio and (tα-
ZEL + tβ-ZEL)/tBM ratio were in good agreement with the ratios in
Henan, China (0.43 and 0.49, respectively) (Li et al, 2018), despite
having a tBM level 1.6 times higher. In these two studies, β-ZEL was the
major metabolite over α-ZEL. In another study carried out in Nanjing,
China, only fZEN and fZAN were detected in less than 10% of the
samples, using a direct analytical method (Fan et al., 2019). Free ZAN
were more than two times higher than fZEN, showing a potential re-
gional difference in ZEN metabolism in China. The tα-ZEL/tβ-ZEL ratio
in our study was lower than that in Europe (0.84–3.2), Africa (1.01 and
1.44), and US (1.8). It even reached 15.2 in Bangladesh. In these
countries, α-ZEL was observed to be the major metabolite in urine.
More consistent results of the ZEN urinary excretion pattern were found
in geographically close populations, such as in German and Sweden, or
in Anhui and Henan. This might be attributed to the similar foods,
cooking methods, and ethnic or genetic factors. It is also worth noting
that unlike the majority of studies, a study of 42 women in Tunisia
showed only α-ZAL was quantified in hydrolyzed urine with a relatively
high concentration of 1.69 ng/mL (Belhassen et al, 2014). In the USA,
ZEN, α/β-ZEL, α/β-ZAL, and ZAN were all detected in urine samples
even though they had not been run through enzyme hydrolysis
(Bandera et al, 2011). In addition to the factors mentioned above, the
variability of these results might also be related to different occurrence
of ZEN and its masked forms in food, but contamination in the matched
food consumed was seldom reported.
Free ZEN positive samples were used to investigate the association
between the levels of fZEN and tBM. On average, the fZEN/tBM ratio
was 0.254. This indicates almost 74.6% of the detected biomarkers
were conjugated forms. The fZEN/tBM ratios between different ages
and genders are illustrated in Table 6. No age- or gender-related dif-
ferences of fZEN/tBM ratios were found. Since matched unhydrolyzed
and enzymatic hydrolyzed urine samples have seldom been analyzed
for ZEN and its metabolites, this is the first fZEN/tBM ratio data from a
large population study.
3.4.2. ZEN internal exposure
Probable daily intake (PDI) represents exposure to ZEN calculated
Fig. 3. Contribution of cereal sources of exposure to ZEN.
Table 3
ZEN biomarkers detected in 199 urine samples after enzymatic digestion.
Compound > LOD (n) > LOQ (n) Mean (ng/mL) Median (ng/mL) P90 (ng/mL) Range (ng/mL)
tZEN 175 112 0.383 0.218 1.14 0.0100–3.77
tα-ZEL 51 9 0.0892 0.0200 0.0650 0.0200–2.66
tβ-ZEL 48 15 0.142 0.0300 0.100 0.0300–2.84
tBM 180 111 0.615 0.294 1.66 0.0600–6.35
For the calculation of means, medians, and P90, toxin concentrations < LOD were set to LOD/2, and toxin concentrations between LOD and LOQ were set to LOQ/2
of the respective compound.
Table 4




Mean ± SD Median P90 Mean ± SD Median P90 Mean ± SD Median P90
Children
37 (16/21)
fZEN 0.0163 ± 0.0284 0.010 0.025 0.0128 ± 0.0060 0.010 0.025 0.0189 ± 0.0375 0.010 0.022
tBM 0.818 ± 1.05 0.427 2.22 1.10 ± 1.40 0.617 3.87 0.603 ± 0.638 0.374 2.00
Adolescents
28 (15/13)
fZEN 0.046 ± 0.065 0.010 0.163 0.0312 ± 0.0550 0.010 0.143 0.0629 ± 0.0734 0.025 0.185
tBM 0.689 ± 0.725 0.422 2.03 0.499 ± 0.550 0.397 1.56 0.908 ± 0.856 0.478 2.52
Adults
83 (40/43)
fZEN 0.0175 ± 0.0272 0.010 0.025 0.0194 ± 0.0317 0.010 0.025 0.0158 ± 0.0224 0.010 0.025
tBM 0.634 ± 1.099 0.162 1.82 0.581 ± 0.930 0.075 1.90 0.686 ± 1.25 0.262 1.83
Elders
51 (25/26)
fZEN 0.0202 ± 0.0469 0.010 0.025 0.0266 ± 0.0645 0.010 0.025 0.0141 ± 0.0182 0.010 0.0145
tBM 0.394 ± 0.548 0.145 0.973 0.564 ± 0.694 0.307 1.92 0.230 ± 0.283 0.0975 0.578
Total
199 (96/103)
fZEN 0.022 ± 0.041 0.010 0.025 0.022 ± 0.044 0.010 0.025 0.022 ± 0.044 0.010 0.025
tBM 0.615 ± 0.933 0.294 1.66 0.650 ± 0.935 0.311 1.97 0.582 ± 0.935 0.262 1.63
For the calculation of means, medians, and P90, toxin concentrations < LOD were set to LOD/2, and toxin concentrations between LOD and LOQ were set to LOQ/2
of the respective compound.
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Table 5
ZEN and its metabolites in human urine.
Countries n Positive n (Analyte) Mean/median range, ng/mL References
Without enzymatic hydrolysis
Germany 101 4 (ZEN-14-GlcA) < LOQ <LOQ Gerding et al, 2014
Bangladesh 95 0 <LOD <LOQ Gerding et al, 2015
Germany 50 0 <LOD <LOQ Gerding et al, 2015
Haiti 142 4 (α-ZEL) 1.46/1.42 0.52–2.49 Gerding et al, 2015
Belgium 40 4 (ZEN) – <LOD–12.6 Ediage et al., 2012
4 (β-ZEL) – 4–24.8
Belgium 32 0 <LOD <LOQ Huybrechts et al, 2015
Belgium 239 1 (α-ZEL) 5.0/5.0 5.0–5.0 Heyndrickx et al, 2015
2 (β-ZEL-14GlcA) 0.8/0.8 0.6–1.0
155 0 <LOD <LOQ
Portugal 95 (24 h urine) 45 (ZEN) 0.17 (median) < LOD–3.98 Martins et al, 2019
0 (α-ZEL) < LOD <LOD
15(ZEN-14GlcA) 0.17 (median) < LOD–25.70
95 (first morning urine) 54 (ZEN) 1.3 (median) < LOD–11.51
4 (α-ZEL) 2.7 (median) < LOD–8.60
14(ZEN-14GlcA) 0.15 (median) < LOD–25.70
Cameroon 220 8 (ZEN) 0.97 (Geometric mean) 0.65–5.0 Ediage et al., 2013
9 (α-ZEL) 0.98 (Geometric mean) 0.26–1.3
18 (β-ZEL) 1.52 (Geometric mean) 0.02–12.5
Cameroon 145 4 (ZEN) 0.22 <LOD–1.42 Abia et al, 2013
2 (α-ZEL) < LOD <LOQ
4 (ZEN-14GlcA) 0.81 3.31–31
7 (total) 0.74 <LOD–21.38
Thailand 60 0 <LOD <LOQ Warth et al, 2014
Nigeria 120 1(ZEN) 0.3 – Ezekiel et al, 2014
8 (ZEN-14GlcA) 9.5 < LOD–44.5
USA 163 90 (ZEN) 1.82 0.05–33.12 Bandera et al, 2011
60 (α-ZEL) 0.63 0.003–10.69
39 (β-ZEL) 0.35 0.05–1.10
29 (ZAN) 0.33 0.07–3.31
35 (α-ZAL) 0.25 0.02–0.57
17 (β-ZAL) 0.29 0.04–0.60
128 (total) 1.86 0.03–48.22
China (Nanjing) 260 18 (ZEN) 0.146 0.056–0.311 Fan et al, 2019
20 (ZAN) 0.342 0.106–1.82
China (Henan) 301 4 (ZEN) – <LOD–0.05 Li et al, 2018
4 (α-ZEL) – < LOQ
3 (β-ZEL) – < LOQ
1 (ZAN) – <LOQ
China (Anhui) 199 42 (ZEN) 0.022 <LOD–0.335 This study
With enzymatic hydrolysis
Italy 52 52 (tZEN) 0.057/0.056 LOQ–0.120 Solfrizzo et al, 2014
52 (tα-ZEL) 0.077/0.074 LOQ–0.176
51 (tβ-ZEL) 0.090/0.088 <LOQ–0.135
tα-ZEL/tβ-ZEL 0.86
(tα-ZEL + tβ-ZEL)/tBM 0.74
Sweden 252 92 (tZEN) 0.03 0.007–0.42 Wallin et al, 2015
53 (tα-ZEL) 0.03 0.029–1.83
45 (tβ-ZEL) 0.02 0.054–1.33
tα-ZEL/tβ-ZEL 1.5
(tα-ZEL + tβ-ZEL)/tBM 0.62
Germany 13 13 (tZEN) 0.031/0.025 0.007–0.009 Föllmann et al, 2016
6 (tα-ZEL) 0.016/0.005 <LOD–0.075
3 (tβ-ZEL) 0.008/0.037 <LOD–0.021
tα-ZEL/tβ-ZEL 2
(tα-ZEL + tβ-ZEL)/tBM 0.44
12 12 (tZEN) 0.042/0.037 0.007–0.009
4 (tα-ZEL) 0.015/0.005 0.01–0.04
2 (tβ-ZEL) 0.009/0.005 0.01–0.04
tα-ZEL/tβ-ZEL 1.67
(tα-ZEL + tβ-ZEL)/tBM 0.36
Germany 60 60 (tZEN) 0.10/0.07 0.04–0.28 Ali and Degen, 2018
60 (tα-ZEL) 0.16/0.13 0.06–0.45
60 (tβ-ZEL) 0.05/0.03 0.01–0.20
60 (total) 0.32
tα-ZEL/tβ-ZEL 3.20
(tα-ZEL + tβ-ZEL)/tBM 0.68
South Africa 54 54 (tZEN) 0.204/0.076 0.012–3.15 Shephard et al, 2013
50 (tα-ZEL) 0.247/0.030 0.009–3.72
40 (tβ-ZEL) 0.244/0.085 0.016–5.94
tα-ZEL/tβ-ZEL 1.01
(tα-ZEL + tβ-ZEL)/tBM 0.71
(continued on next page)
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where CtBM is the concentration of the tBM (ng/mL) (sum of the total
ZEN, α-ZOL, and β-ZEL) of individuals; V is the urine excretion volume
(mL) based on assumed daily urine excretion of 500 mL for children and
1500 mL for adolescents, adults, and elders (Gong et al., 2015);W is the
individual body weight (kg); E is the excretion rate. An excretion rate of
36.8% (including 28.4% as total ZEN and 8.3% as α-ZEL) has been
derived from a piglet study (Gambacorta et al., 2013) and was used in
some human biomonitoring studies to assess human exposure, owing to
very limited data on urinary excretion of ZEN in humans (Solfrizzo
et al., 2014; Wallin et al., 2015; Föllmann et al., 2016). PDIs of ZEN for
different populations are presented in Table 7. The average PDI was
41.6 ng/kg bw/day, equivalent to 16.6% of the TDI set by EFSA. Five
participants (2.5%) exceeded the EFSA’s TDI of 0.25 μg/kg bw/day.
These five participants were from different families and included 3 fe-
male adults and 2 male children, one being a 4-year-old boy, whose EDI
value also exceeded the TDI. Among the four population groups,
Table 5 (continued)
Countries n Positive n (Analyte) Mean/median range, ng/mL References
Nigeria 120 98 (tZEN) 0.75/0.20 0.03–19.99 Šarkanj et al, 2018
5 (tα-ZEL) 1.27/0.87 0.52–2.52
7 (tβ-ZEL) 0.88/0.33 0.06–2.74
tα-ZEL/tβ-ZEL 1.44
(tα-ZEL + tβ-ZEL)/tBM 0.74
Tunisia 42 1 (tZEN) <LOQ <LOQ Belhassen et al, 2014
8 (tα-ZAL) 1.69/1.43 0.76–3.17
1 (tβ-ZAL) < LOQ <LOQ
Bangladesh 62 (in winter) 62 (tZEN) 0.028/0.021 0.017–0.084 Ali and Degen, 2019
62 (tα-ZEL) 0.198/0.194 0.170–0.346
11 (tβ-ZEL) 0.013/0.013 <LOD–0.022
tα-ZEL/tβ-ZEL 15.2
(tα-ZEL + tβ-ZEL)/tBM 0.88
62 (in summer) 62 (tZEN) 0.040/0.027 0.015–0.201
62 (tα-ZEL) 0.182/0.183 0.100–0.286
55 (tβ-ZEL) 0.018/0.011 <LOD–0.090
tα-ZEL/tβ-ZEL 10.1
(tα-ZEL + tβ-ZEL)/tBM 0.83
China (Henan) 301 214 (tZEN) 0.24/0.15 <LOQ–3.7 Li et al, 2018
3 (tZAN) 0.017/0.015 <LOQ–0.52
12 (tα-ZEL) 0.035/0.020 <LOQ–2.6
66 (tβ-ZEL) 0.082/0.030 <LOQ–2.1
tα-ZEL/tβ-ZEL 0.43
(tα-ZEL + tβ-ZEL)/tBM 0.31
China (Anhui) 199 112 (tZEN) 0.383/0.218 <LOQ–3.77 This study
9 (tα-ZEL) 0.089/0.020 <LOQ–2.66
15 (tβ-ZEL) 0.142/0.030 <LOQ–2.84
111 (total) 0.615/0.294 <LOQ–6.35
tα-ZEL/tβ-ZEL 0.63
(tα-ZEL + tβ-ZEL)/tBM 0.38
Table 6
fZEN/tBM ratios by different age groups.
Age n (M/F) Total Male Female
Mean ± SD Median Mean ± SD Median Mean ± SD Median
Children 5 (3/2) 0.230 ± 0.187 0.333 0.131 ± 0.176 0.0303 0.380 ± 0.0655 0.380
Adolescents 12 (4/8) 0.270 ± 0.555 0.0632 0.134 ± 0.172 0.0606 0.338 ± 0.674 0.0639
Adults 16 (8/8) 0.285 ± 0.147 0.333 0.306 ± 0.0987 0.333 0.264 ± 0.188 0.333
Elders 9 (7/2) 0.193 ± 0.152 0.143 0.144 ± 0.135 0.0852 0.362 ± 0.0406 0.362
Total 42 (22/20) 0.254 ± 0.316 0.332 0.199 ± 0.150 0.237 0.315 ± 0.428 0.333
Only samples having detectable fZEN (fZEN > LOD) (n = 42, 22 males and 20 females) were included to calculate the fZEN/tBM ratio.
Table 7
Probable daily intake of ZEN for different age groups (ng/kg bw/day).
Age n (M/F) Total Male Female
Mean ± SD Median P90 Mean ± SD Median P90 Mean ± SD Median P90
Children
3-12y
37 (16/21) 47.5 ± 71.4 24.3 138 65.3 ± 100 23.3 279 33.7 ± 33.8 26.6 92.4
Adolescents
13-18y
28 (15/13) 54.0 ± 59.2 29.5 145 36.2 ± 37.5 29.2 109 74.8 ± 73.3 38.5 210.2
Adults
19-65y
83 (40/43) 42.7 ± 75.7 9.42 117 36.8 ± 61.4 5.66 92.4 48.2 ± 87.3 16.6 122
Elders
> 65y
51 (25/26) 28.6 ± 41.8 11.8 63.8 39.4 ± 52.6 19.7 134 18.2 ± 24.5 7.47 42.2
Total 199 (96/103) 41.6 ± 65.5 18.4 120 42.1 ± 64.5 19.1 118 41.0 ± 66.7 16.6 120
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adolescents had slightly higher PDI on average, but no significant dif-
ferences were found (P = 0.069).
3.5. Relationship between human dietary and internal exposure
To investigate the association of ZEN dietary and internal exposure,
199 subjects who had matched dietary and urinary data were included.
There was a significant correlation between EDI and PDI, with a
Spearman correlation coefficient of 0.344 (p < 0.01). Among the four
age groups, the correlation in children was not significant (0.312,
p = 0.060). In the other three age groups, the Spearman correlation
coefficients were 0.506 (p < 0.01), 0.328 (p < 0.01), and 0.275
(p < 0.05) in adolescents, adults, and elders, respectively. Despite the
overall positive correlation, they showed different trends with age. The
correlation between dietary and internal exposure to ZEN appears to be
stronger in adolescents than in other populations.
In this study, both the EDI and PDI were markedly below the TDI set
by EFSA (only 10% and 16% of the TDI, respectively, Table 8). PDI was
1.6 times higher than EDI. Four possible causes may explain the dif-
ferences. First, as mentioned above, only cereal foods were collected in
our duplicate diet study. Thus, the EDI could be underestimated.
Second, the morning urine might be more concentrated, with higher
excretion levels resulting in higher PDI. Third, the internal exposure
reflects the total exposure via all possible routes. Environmental and
occupational exposure may also contribute, considering the living en-
vironment (farmland) of the subjects. Most importantly, the masked
ZEN co-occurred with ZEN in crops, including the phase I metabolites
ZAN, α-/β-ZEL, and α-/β-ZAL and phase II glucoside and sulfate con-
jugates (EFSA, 2016). In this study, phase I metabolites were included
in the food analysis, but the phase II conjugates in food, which could
also contribute to ZEN exposure and convert into ZEN urinary bio-
markers, were not measured. Despite the lack of masked ZEN occur-
rence data in Chinese crops, European studies reported the sum of
phase II conjugates accounted for 20.4%~51.6% (Nathanail et al.,
2015) and 37% (De Boevre et al., 2013) of the total ZEN related com-
pounds in cereals and cereal-based foods. As a result, the dietary ex-
posure to ZEN obtained in our study was underestimated, and this
might be a major cause of the difference between EDI and PDI.
From Fig. 4, the trends of PDI between ages and genders were
consistent with the EDI except the internal exposure was much higher
in adolescents (54.0 ng/kg bw/day), with the data shown in Table 2
and Table 7 separately. This suggests that the ZEN metabolism pattern
might be different between subpopulation groups, although it is merely
derived from very limited numbers of participants in each group.
Considering the larger SD value of PDI than EDI, not only can the ex-
cretion of ZEN be determined by the intake of ZEN, but it can also vary
between genders, ages, and individuals as well.
In order to further study the variability in ZEN excretion, we cal-
culated the ratio of PDI/EDI for 199 individuals as an indicator of the
excretion efficiency between subpopulations. The results of the PDI/EDI
in populations are summarized in Table 9.
The mean PDI/EDI ratios for children (n = 37), adolescents
(n = 28), adults (n = 83), and elders (n = 51) were 2.07, 2.89, 2.27
and 1.57, respectively. No significant gender difference was observed
(p = 0.871). However, with the age-related comparison, there were
differences in the PDI/EDI between age groups (p < 0.05). Their ex-
cretion capabilities were in order of adolescents > adults >
children > elders, although the sample size of each group was in-
sufficient to draw firm conclusions. This result suggests adolescents are
more efficient in ZEN metabolism than any other age group. As a result,
there is potential to overestimate exposure to ZEN in adolescents when
using the same excretion rate to assess internal exposure. In addition,
further validation of urinary ZEN biomarkers, especially the impacts of
age and gender on the excretion of ZEN and its metabolites, is needed.
Table 8
Comparison of dietary exposure and internal exposure.
Exposure Mean ± SD P50 P75 P90 Range Exceeding (size, rate%)
(ng/kg bw/d) TDIb PMTDIc
EDI 25.6 ± 38.6 15.7 25.2 57.6 1.4–344.3 2 (1.0%) 0
PDIa 41.6 ± 65.5 18.4 42.6 120.1 2.2–431.2 5 (2.5%) 0
a: PDI was calculated with ER of 36.8%; b: TDI is 250 ng/kg bw/d set by EFSA; c: PMTDI is 500 ng/kg bw/d set by JECFA.
Fig.4. Comparison of dietary exposure and internal exposure. (A) Dietary ex-
posure of ZEN, (B) internal exposure of ZEN calculated with an excretion rate of
36.8%.
Table 9
The ratio of PDI/EDI in different age groups.
Subgroup n (M/F) Mean ± SD P50 P75 P90
Children 37 (16/21) 2.07 ± 2.94 0.89 2.29 7.25
Adolescents 28 (15/13) 2.89 ± 2.78 2.17 3.58 7.88
Adults 83 (40/43) 2.27 ± 3.39 0.91 2.43 7.64
Elders 51 (25/26) 1.57 ± 2.11 0.79 1.82 3.48
Total 199 (96/103) 2.14 ± 2.95 0.94 2.45 5.79
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4. Conclusions
In this research, the exposure assessment of ZEN in a Chinese cohort
of 199 from 74 families was studied. We employed both duplicate diet
study based on food analysis and human biomonitoring approaches in
the assessment of ZEN exposure. Our validated sensitive LC-MS/MS
methods for ZEN and five metabolites of ZAN, α-/β-ZEL, and α-/β-ZAL
in food and urine matrices generated reliable data in the exposure as-
sessment. From the results of the duplicate diet study, ZEN was the
predominant mycoestrogen contaminant in food samples. The cereal
sources of maize, glutinous rice, and wheat were contaminated with
relatively high ZEN concentrations. Wheat contributed to nearly 80% of
the ZEN intake. The average EDI of ZEN was markedly below TDI set by
EFSA. Children (n = 37) had the highest EDI level, with 15% of TDI.
From the human biomonitoring, conjugates of ZEN, α-ZEL, and β-ZEL
were the main metabolites of ZEN in urine. Adolescents (n = 28) had
significantly higher fZEN and tZEN levels in urine. According to the
human biomonitoring data, internal exposure (PDI) was 1.6 times
higher than the calculated dietary exposure. Both EDI and PDI were at
the safe level compared to TDI. The correlation between dietary and
internal assessment has seldom been studied, especially in the case of
ZEN. Thus, this is the first ZEN exposure assessment incorporating both
diet study and corresponding human biomonitoring in a human cohort.
Moreover, the relationship between dietary and internal exposure has
been revealed for the first time. A significant correlation is observed,
although it appears not very strong. Uncertainties from gender, age, and
interindividual factors could hamper the accurate translation from ur-
inary ZEN biomarkers to dietary intake. Thus, we calculated the PDI/
EDI ratio to investigate differences in excretion capabilities between
subpopulations. Based on the very limited number of participants,
significant age-related differences were found and worthy of further
investigation. Despite the limitations, mainly not including conjugated
forms of masked ZEN in food analysis, this work showed a significant
correlation between food-based approach and biomarker-based ap-
proach, both of which can serve as reliable and powerful tools for ex-
posure assessment.
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